Reclip Tablet (Linagliptin)
Linagliptin 5mg
Tablet · Prescription medication
You&Life Science Co., Ltd.
MFDS item code 201907593 · Approved 2019.10.31
This product's status changed to Expired on 2024.10.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood sugar control in type 2 diabetes
This medication is used to help control blood sugar in patients with type 2 diabetes. It can be administered as monotherapy, and when blood sugar control is difficult with monotherapy during initial treatment without any prior experience with other diabetes medication, it should be used in combination with Metformin. Additionally, this medication can be used when sufficient blood sugar control is not achieved with monotherapies of Metformin or sulfonylureas. It can also be used in conjunction with insulin therapy when blood sugar control is inadequate, either alone or in combination with Metformin. Furthermore, when blood sugar control is difficult with combined therapy of sulfonylureas and Metformin or Empagliflozin (25mg) combined with Metformin, this medication can be used to improve blood sugar.
The recommended dosage for this medication is 5mg once daily. It can be taken regardless of meals.
This medication should not be used in patients who have allergies to the active ingredient or other components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. When used together with insulin or sulfonylureas, which can cause hypoglycemia, the risk of hypoglycemia may increase, so caution should be exercised. In such cases, the dosage of insulin or insulin secretagogues may need to be reduced. Use of this medication is not recommended in patients with heart failure, particularly those with severe heart failure, and it should be used cautiously in patients with mild heart failure. Acute pancreatitis can occur during treatment with this medication, so if you experience persistent and severe abdominal pain, you should stop taking the medication immediately and consult your doctor. There may be an appearance of bullous skin conditions such as pemphigus vulgaris, so if blisters or skin erosions appear, you should notify your doctor immediately and discontinue use of the medication. While this medication is generally safe, adverse reactions such as hypoglycemia, infection, gastrointestinal disturbances, skin rashes, and arthralgia may occur, so if symptoms are severe or persistent, you should consult your doctor. Particularly if severe arthralgia or disabilities occur, this medication may be the cause, and consideration of discontinuation should be made if such symptoms arise. The safety of this medication has not been established in pregnant or breastfeeding individuals, so its use is not recommended, and care should be taken when administering it to lactating mothers. Use is not recommended for children under 10 years of age, and in adolescents over 10 years of age, caution is necessary due to limited clinical experience. Elderly individuals may use this medication without special dose adjustments, and it can also be administered without dosage adjustments to patients with impaired renal or liver function. Interactions with other medications are low, but effects may vary when used with certain medications, so it is essential to consult with a doctor or pharmacist. There is no specific antidote for overdose, so appropriate treatment based on symptoms is important, and the medication should be kept out of the reach of children.
Urticaria, angioedema, pancreatitis, bullous pemphigoid, severe and disabling arthralgia, acute pancreatitis, bullous pemphigoid, pneumonia, dyspnea, congestive heart failure, acute myocardial infarction, cardiac arrest, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, severe allergic reactions, severe skin adverse reactions, respiratory issues, liver abnormalities (jaundice), severe neurological symptoms, severe swelling or urination abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius. This will help retain the medication's effectiveness for a long time and prevent deterioration.
Round film-coated tablets that are convex on both sides with sharp-edged bright red color
For domestic use - 30 tablets/box [30 tablets (10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 5mg
Tablet · Prescription medication
You&Life Science Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.